Stock Agreements in the Biotechnology Industry

3,989 Contracts & Agreements

Browse by Company

4D Molecular Therapeutics Inc (2 contracts)
89bio, Inc. (2)
AbbVie Inc. (26)
ABEONA THERAPEUTICS INC. (4)
ACADIA PHARMACEUTICALS INC (4)
ACCELERON PHARMA INC (4)
Accustem Sciences Inc. (2)
Achaogen, Inc. (6)
ACHIEVE LIFE SCIENCES, INC. (8)
Acorda Therapeutics (14)
Actinium Pharmaceuticals, Inc. (16)
Acumen Pharmaceuticals, Inc. (2)
Acurx Pharmaceuticals, LLC (1)
Adagio Therapeutics, Inc. (4)
Adamas Pharmaceuticals Inc (6)
Adhera Therapeutics, Inc. (12)
ADiTx Therapeutics, Inc. (4)
ADMA BIOLOGICS, INC. (6)
ADURO BIOTECH, INC. (7)
Advaxis, Inc. (9)
Adverum Biotechnologies, Inc. (6)
Aeglea BioTherapeutics, Inc. (14)
Aerovate Therapeutics, Inc. (3)
AGENUS INC (15)
AgeX Therapeutics, Inc. (6)
AGIOS PHARMACEUTICALS INC (4)
AILERON THERAPEUTICS INC (2)
Aimmune Therapeutics, Inc. (7)
AKCEA THERAPEUTICS, INC. (3)
Akebia Therapeutics, Inc. (6)
Akero Therapeutics, Inc. (4)
Akouos, Inc. (12)
ALBIREO PHARMA, INC. (10)
Aldeyra Therapeutics, Inc. (3)
Alector, Inc. (4)
Alexion Pharmaceuticals (8)
Aligos Therapeutics, Inc. (3)
Allakos Inc. (4)
Allarity Therapeutics, Inc. (3)
Allena Pharmaceuticals, Inc. (2)
Alliqua BioMedical, Inc. (31)
Allogene Therapeutics, Inc. (4)
Allovir, Inc. (4)
ALNYLAM PHARMACEUTICALS, INC. (23)
Alpha Healthcare Acquisition Corp. (10)
ALPINE IMMUNE SCIENCES, INC. (15)
Altimmune, Inc. (7)
ALX ONCOLOGY HOLDINGS INC (2)
Alzamend Neuro, Inc. (1)
AMARILLO BIOSCIENCES INC (10)
AMARIN CORP PLC (8)
Amgen Inc. (10)
AMICUS THERAPEUTICS, INC. (10)
AmpliPhi Biosciences Corp (4)
Amplitude Healthcare Acquisition Corp (5)
ANAPTYSBIO INC (1)
ANAVEX LIFE SCIENCES CORP. (3)
Anika Therapeutics (3)
Anixa Biosciences Inc (6)
Annexon, Inc. (6)
Annovis Bio, Inc. (2)
Apellis Pharmaceuticals, Inc. (3)
APPLIED GENETIC TECHNOLOGIES CORP (2)
Applied Molecular Transport Inc. (3)
Applied Therapeutics Inc. (2)
Aprea Therapeutics, Inc. (6)
Aptevo Therapeutics Inc. (2)
Aptinyx Inc. (1)
AQUINOX PHARMACEUTICALS, INC (3)
Aravive, Inc. (5)
Arbutus Biopharma Corp (2)
ARCA biopharma, Inc. (17)
Arcellx, Inc. (7)
Arcturus Therapeutics Holdings Inc. (3)
Arcus Biosciences, Inc. (7)
Arcutis Biotherapeutics, Inc. (3)
ARDELYX, INC. (2)
ARENA PHARMACEUTICALS INC (15)
Aridis Pharmaceuticals, Inc. (1)
ARROWHEAD PHARMACEUTICALS, INC. (20)
Arsanis, Inc. (5)
Artiva Biotherapeutics, Inc. (5)
ARYA Sciences Acquisition Corp II (3)
ASSEMBLY BIOSCIENCES, INC. (10)
Atara Biotherapeutics, Inc. (6)
Athenex, Inc. (4)
ATHERSYS, INC (11)
ATOSSA GENETICS INC (10)
Atreca, Inc. (5)
aTYR PHARMA INC (10)
Aura Biosciences, Inc. (3)
Aurinia Pharmaceuticals Inc. (1)
AVEO PHARMACEUTICALS INC (13)
Avid Bioservices, Inc. (6)
Avidity Biosciences, Inc. (2)
Avita Therapeutics, Inc. (4)
AVROBIO, Inc. (4)
Axcella Health Inc. (2)
Axovant Sciences Ltd. (1)
Ayala Pharmaceuticals, Inc. (1)
AZIYO BIOLOGICS, INC. (8)
AzurRx BioPharma, Inc. (3)
BCTG Acquisition Corp. (8)
Beam Therapeutics Inc. (7)
BELLICUM PHARMACEUTICALS, INC (2)
Big Cypress Acquisition Corp. (3)
BIO-PATH HOLDINGS INC (1)
bioAffinity Technologies, Inc. (1)
BioAtla, Inc. (13)
BioCardia, Inc. (4)
BIOCEPT INC (10)
BIOCRYST PHARMACEUTICALS INC (9)
Biogen Inc. (24)
Biohaven Pharmaceutical Holding Co Ltd. (2)
BioLife4D Corp (3)
BIOMARIN PHARMACEUTICAL INC (11)
Biomea Fusion, Inc. (2)
BioNexus Gene Lab Coporation (2)
BioRestorative Therapies, Inc. (26)
BIOSPECIFICS TECHNOLOGIES CORP (7)
Biostage, Inc. (3)
BIOTIME INC (30)
BIOVIE INC. (2)
BioXcel Therapeutics, Inc. (2)
BIOXYTRAN, INC (7)
Black Diamond Therapeutics, Inc. (3)
Blue Water Vaccines Inc. (4)
bluebird bio, Inc. (4)
Blueprint Medicines Corp (3)
Bolt Biotherapeutics, Inc. (2)
Bone Biologics Corp (7)
BRAINSTORM CELL THERAPEUTICS INC. (7)
BriaCell Therapeutics Corp. (1)
BridgeBio Pharma, Inc. (8)
BullFrog AI Holdings, Inc. (1)
BURZYNSKI RESEARCH INSTITUTE INC (1)
C4 Therapeutics, Inc. (4)
Cabaletta Bio, Inc. (4)
CALADRIUS BIOSCIENCES, INC. (13)
Calithera Biosciences, Inc. (4)
Calyxt, Inc. (2)
CANCER GENETICS, INC (13)
Candel Therapeutics, Inc. (3)
CAPRICOR THERAPEUTICS, INC. (15)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (5)
Capstone Therapeutics Corp. (5)
CareDx, Inc. (2)
Caribou Biosciences, Inc. (5)
CASI Pharmaceuticals, Inc. (7)
CASTLE BIOSCIENCES INC (7)
CATABASIS PHARMACEUTICALS INC (5)
CATALYST BIOSCIENCES, INC. (12)
CATALYST PHARMACEUTICALS, INC. (12)
CEL SCI CORP (2)
Celcuity Inc. (2)
Cell Source, Inc. (4)
Celldex Therapeutics, Inc. (14)
Cellectar Biosciences, Inc. (17)
Cellular Biomedicine Group, Inc. (9)
Celsion CORP (8)
Centessa Pharmaceuticals Ltd (1)
Century Therapeutics, Inc. (12)
CEREBAIN BIOTECH CORP. (5)
Chanticleer Holdings, Inc. (9)
Chardan Healthcare Acquisition 2 Corp. (4)
Chardan Healthcare Acquisition Corp. (3)
Checkmate Pharmaceuticals, Inc. (4)
Chelsea Worldwide Inc. (2)
ChemoCentryx, Inc. (9)
CHIMERIX INC (5)
Cibus Global, Ltd. (5)
Cidara Therapeutics, Inc. (5)
CLEVELAND BIOLABS INC (4)
Clovis Oncology, Inc. (4)
CM Life Sciences III Inc. (6)
Codiak BioSciences, Inc. (6)
CohBar, Inc. (1)
Coherus BioSciences, Inc. (4)
Comera Life Sciences Holdings, Inc. (1)
Conatus Pharmaceuticals Inc. (10)
CONCERT PHARMACEUTICALS, INC. (4)
Consonance-HFW Acquisition Corp. (4)
Constellation Alpha Capital Corp. (7)
CONSTELLATION PHARMACEUTICALS INC (2)
CONTRAFECT Corp (7)
Corbus Pharmaceuticals Holdings, Inc. (7)
Cortexyme, Inc. (6)
Crinetics Pharmaceuticals, Inc. (2)
CRISPR Therapeutics AG (2)
CTI BIOPHARMA CORP (6)
Cue Biopharma, Inc. (3)
Cullinan Oncology, LLC (4)
Curative Biotechnology Inc (10)
CURIS INC (13)
Cyclacel Pharmaceuticals, Inc. (9)
Cyclerion Therapeutics, Inc. (5)
CytoDyn Inc. (18)
Cytokinetics, Incorporated (16)
CytomX Therapeutics, Inc. (2)
CYTORI THERAPEUTICS, INC. (21)
CYTRX CORP (9)
Day One Biopharmaceuticals Holding Co LLC (3)
DBV Technologies S.A. (3)
Decibel Therapeutics, Inc. (4)
DECIPHER BIOSCIENCES, INC. (2)
Deciphera Pharmaceuticals, Inc. (4)
DelMar Pharmaceuticals, Inc. (4)
Denali Therapeutics Inc. (12)
Dermira, Inc. (3)
Design Therapeutics, Inc. (4)
DiaMedica Therapeutics Inc. (3)
Dicerna Pharmaceuticals Inc (11)
Diffusion Pharmaceuticals Inc. (10)
Digital Development Partners, Inc. (1)
DYADIC INTERNATIONAL INC (2)
Dynamics Special Purpose Corp. (6)
DYNAVAX TECHNOLOGIES CORP (9)
Dyne Therapeutics, Inc. (3)
Eagle Pharmaceuticals, Inc. (5)
Edge Therapeutics, Inc. (4)
Editas Medicine, Inc. (6)
Eidos Therapeutics, Inc. (2)
Eiger BioPharmaceuticals, Inc. (6)
Elevation Oncology, Inc. (2)
Eliem Therapeutics, Inc. (2)
Emerald Bioscience, Inc. (8)
Emergent BioSolutions Inc. (21)
Enanta Pharmaceuticals, Inc. (4)
ENDONOVO THERAPEUTICS, INC. (3)
Enochian Biosciences Inc (2)
Entasis Therapeutics Holdings Inc. (4)
Entrada Therapeutics, Inc. (3)
Environmental Impact Acquisition Corp (6)
ENZON PHARMACEUTICALS, INC. (1)
Epizyme, Inc. (6)
Equillium, Inc. (5)
Erasca, Inc. (3)
Esperion Therapeutics, Inc. (7)
ESSA Pharma Inc. (4)
Evelo Biosciences, Inc. (5)
EVOLUTIONARY GENOMICS, INC. (2)
EXACT SCIENCES CORP (10)
Exelixis (16)
EXICURE, INC. (5)
FATE THERAPEUTICS INC (5)
FENNEC PHARMACEUTICALS INC. (3)
Fibrocell Science, Inc. (7)
FIBROGEN INC (4)
Finch Therapeutics Group, Inc. (3)
FIVE PRIME THERAPEUTICS INC (4)
Flex Pharma, Inc. (7)
Flexion Therapeutics Inc (5)
FLUOROPHARMA MEDICAL, INC. (3)
Foghorn Therapeutics Inc. (3)
Forma Therapeutics Holdings, Inc., (2)
Fortress Biotech, Inc. (12)
Forty Seven, Inc. (2)
Frequency Therapeutics, Inc. (5)
FS Development Corp. (9)
FS Development Corp. II (5)
G1 Therapeutics, Inc. (1)
Gain Therapeutics, Inc. (3)
GALECTIN THERAPEUTICS INC (11)
Galecto Inc. (4)
Galera Therapeutics, Inc. (2)
Gemphire Therapeutics Inc. (5)
Gene Biotherapeutics, Inc. (3)
GENELUX CORP (7)
Generation Bio Co. (3)
GENEREX BIOTECHNOLOGY CORP (35)
GENOCEA BIOSCIENCES, INC. (4)
Genprex, Inc. (5)
GeoVax Labs, Inc. (23)
GERON CORP (20)
Gilead Sciences (27)
Global Blood Therapeutics, Inc. (3)
GLYCOMIMETICS INC (4)
Gossamer Bio, Inc. (5)
Grail, Inc. (3)
Graphite Bio, Inc. (5)
Greenwich LifeSciences, Inc. (1)
Gritstone Oncology, Inc. (5)
GT Biopharma, Inc. (7)
GTX INC (16)
GX Acquisition Corp. (3)
HALOZYME THERAPEUTICS INC (25)
HARBOR DIVERSIFIED, INC. (7)
Harpoon Therapeutics, Inc. (5)
HCW Biologics Inc. (3)
Health Sciences Acquisitions Corp (6)
HEAT BIOLOGICS, INC. (15)
HedgePath Pharmaceuticals, Inc. (2)
HEMISPHERX BIOPHARMA INC (16)
HERON THERAPEUTICS, INC. (2)
HilleVax, Inc. (2)
Hillstream BioPharma Inc. (1)
HISTOGENICS CORP (13)
Homology Medicines, Inc. (6)
HOOKIPA Pharma Inc. (5)
HST Global, Inc. (1)
HUMANIGEN, INC (4)
iBio, Inc. (6)
Icosavax, Inc. (2)
IDEAYA Biosciences, Inc. (6)
IDERA PHARMACEUTICALS, INC. (20)
IGM Biosciences, Inc. (10)
Imago BioSciences, Inc. (2)
Immix Biopharma, Inc. (5)
IMMUCELL CORP (2)
IMMUNE PHARMACEUTICALS INC (9)
Immune Therapeutics, Inc. (3)
Immuneering Corp (2)
ImmunoCellular Therapeutics, Ltd. (6)
IMMUNOGEN INC (13)
Immunome Inc. (5)
IMMUNOMEDICS INC (17)
IMPEL NEUROPHARMA INC (2)
IN8BIO, INC. (2)
Incyte (22)
INFINITY PHARMACEUTICALS, INC. (17)
Inhibikase Therapeutics, Inc. (2)
Inhibrx, Inc. (2)
InMed Pharmaceuticals Inc. (2)
Inmune Bio, Inc. (3)
Innovation Pharmaceuticals Inc. (10)
INOVIO PHARMACEUTICALS, INC. (9)
Inozyme Pharma, Inc. (3)
INSMED Inc (7)
Inspyr Therapeutics, Inc. (9)
Instil Bio, Inc. (1)
Intellia Therapeutics, Inc. (4)
INTERCEPT PHARMACEUTICALS, INC. (16)
International Stem Cell CORP (16)
INTREXON CORP (10)
Intrinsic Medicine, Inc. (3)
Invitae Corp (5)
IO Biotech, Inc. (2)
IONIS PHARMACEUTICALS INC (8)
IOVANCE BIOTHERAPEUTICS, INC. (14)
IRONWOOD PHARMACEUTICALS INC (5)
Isoray, Inc. (20)
iTeos Therapeutics, Inc. (4)
Janux Therapeutics, Inc. (3)
Jounce Therapeutics, Inc. (5)
Kadmon Holdings, Inc. (5)
KalVista Pharmaceuticals, Inc. (5)
Karuna Therapeutics, Inc. (3)
Karyopharm Therapeutics Inc. (9)
KBL MERGER CORP. IV (5)
Keros Therapeutics, Inc. (3)
Kezar Life Sciences, Inc. (3)
Kindred Biosciences, Inc. (2)
Kinnate Biopharma Inc. (2)
Kiromic Biopharma, Inc. (3)
KIWA BIO-TECH PRODUCTS GROUP CORP (5)
Kodiak Sciences Inc. (4)
Kronos Bio, Inc. (5)
Krystal Biotech, Inc. (4)
Kura Oncology, Inc. (2)
Kymera Therapeutics, Inc. (5)
LA JOLLA PHARMACEUTICAL CO (7)
Lantern Pharma Inc. (2)
LEAP THERAPEUTICS, INC. (1)
Leisure Acquisition Corp. (6)
LEXICON PHARMACEUTICALS, INC. (20)
LifeSci Acquisition Corp. (6)
Ligand Pharmaceuticals Incorporated (22)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (2)
Locust Walk Acquisition Corp. (5)
LogicBio Therapeutics, Inc. (2)
LONGEVERON LLC (2)
Lyell Immunopharma, Inc. (3)
MACROGENICS INC (6)
MADRIGAL PHARMACEUTICALS, INC. (16)
Magenta Therapeutics, Inc. (5)
MAIA Biotechnology, Inc. (2)
MANHATTAN SCIENTIFICS INC (1)
MANNKIND CORP (14)
MARIZYME INC (18)
Marker Therapeutics, Inc. (19)
MATEON THERAPEUTICS INC (9)
Matinas BioPharma Holdings, Inc. (3)
MAXCYTE, INC. (2)
MEDICINOVA INC (9)
Medovex Corp. (1)
MEI Pharma, Inc. (14)
MERRIMACK PHARMACEUTICALS INC (3)
Mersana Therapeutics, Inc. (6)
Metacrine, Inc. (4)
Millendo Therapeutics, Inc. (14)
MiMedx Group, Inc. (23)
Minerva Neurosciences, Inc. (8)
MiNK Therapeutics, Inc. (4)
MIRAGEN THERAPEUTICS, INC. (5)
Mirati Therapeutics, Inc. (5)
Mirum Pharmaceuticals, Inc. (9)
Moderna, Inc. (14)
Molecular Templates, Inc. (9)
Moleculin Biotech, Inc. (3)
Momenta Pharmaceuticals, Inc. (6)
Monopar Therapeutics (6)
Monte Rosa Therapeutics, Inc. (4)
Morphic Holding, Inc. (5)
MUSTANG BIO, INC. (5)
Myovant Sciences Ltd. (3)
Myriad Genetics, Inc. (12)
NANOVIRICIDES, INC. (18)
NantKwest, Inc. (3)
Natera, Inc. (5)
NAVIDEA BIOPHARMACEUTICALS, INC. (25)
NEUROBIOLOGICAL TECHNOLOGIES INC (1)
NEUROCRINE BIOSCIENCES INC (3)
NEUROTROPE BIOSCIENCE, INC. (2)
Neurotrope, Inc. (2)
NEWLINK GENETICS CORP (18)
NexImmune, Inc. (1)
NextCure, Inc. (1)
Nkarta, Inc. (5)
NORTHWEST BIOTHERAPEUTICS INC (14)
NOVAVAX INC (11)
Novus Therapeutics, Inc. (7)
NTN BUZZTIME INC (7)
Nuo Therapeutics, Inc. (4)
Nurix Therapeutics, Inc. (2)
Nuvalent, Inc. (4)
Nuvectis Pharma, Inc. (2)
Ohr Pharmaceutical Inc (11)
Olema Pharmaceuticals, Inc. (9)
Olivia Ventures, Inc. (1)
Omega Therapeutics, Inc. (3)
OncBioMune Pharmaceuticals, Inc (9)
OncoCyte Corp (3)
Oncorus, Inc. (3)
ONCOSEC MEDICAL Inc (9)
OPGEN INC (11)
Ophthotech Corp. (6)
Opko Health, Inc. (8)
ORAGENICS INC (23)
Organicell Regenerative Medicine, Inc. (6)
Organogenesis Holdings Inc. (2)
ORGANOVO HOLDINGS, INC. (8)
Orgenesis Inc. (2)
Oric Pharmaceuticals, Inc. (4)
Outlook Therapeutics, Inc. (3)
Ovid Therapeutics Inc. (3)
Oyster Point Pharma, Inc. (4)
PALATIN TECHNOLOGIES INC (1)
Pasithea Therapeutics Corp. (2)
Passage BIO, Inc. (2)
PDL BIOPHARMA, INC. (18)
PepGen Inc. (3)
Petra Acquisition Inc. (5)
Pfenex Inc. (3)
PharmaCyte Biotech, Inc. (10)
PhaseBio Pharmaceuticals Inc (3)
Phio Pharmaceuticals Corp. (6)
PIERIS PHARMACEUTICALS, INC. (10)
PLURISTEM THERAPEUTICS INC (15)
PMV Pharmaceuticals, Inc. (4)
POLARITYTE, INC. (19)
PORTOLA PHARMACEUTICALS INC (6)
Poseida Therapeutics, Inc. (4)
Praxis Precision Medicines, Inc. (2)
PRECISION BIOSCIENCES INC (4)
Prelude Therapeutics Inc (5)
PREMIER BIOMEDICAL INC (2)
Prevail Therapeutics Inc. (2)
Principia Biopharma Inc. (3)
Progenics Pharmaceuticals, Inc. (5)
PROGENITY, INC. (11)
Prometheus Biosciences, Inc. (2)
ProMIS Neurosciences Inc. (1)
Propanc Biopharma, Inc. (3)
Protagenic Therapeutics, Inc. (7)
Protagonist Therapeutics, Inc (1)
Protalix BioTherapeutics, Inc. (5)
PROTEON THERAPEUTICS INC (6)
PROTEOSTASIS THERAPEUTICS, INC. (2)
ProtoKinetix, Inc. (1)
PTC THERAPEUTICS, INC. (9)
Pyxis Oncology, Inc. (2)
Q BioMed Inc. (1)
Qrons Inc. (1)
Radius Health, Inc. (12)
Rallybio Corp (2)
RAPT Therapeutics, Inc. (4)
Rasna Therapeutics Inc. (1)
RECURSION PHARMACEUTICALS, INC. (4)
Regeneron Pharmaceuticals (10)
REGENERX BIOPHARMACEUTICALS INC (2)
REGENXBIO Inc. (2)
Regulus Therapeutics Inc. (9)
Relay Therapeutics, Inc. (4)
Reneo Pharmaceuticals, Inc. (5)
RenovaCare, Inc. (4)
RenovoRx, Inc. (1)
Replimune Group, Inc. (11)
Retrophin, Inc. (8)
Revolution Medicines, Inc. (4)
REXAHN PHARMACEUTICALS, INC. (10)
Rezolute, Inc. (21)
RHYTHM PHARMACEUTICALS, INC. (5)
Rich Pharmaceuticals, Inc. (4)
RIGEL PHARMACEUTICALS INC (14)
RITTER PHARMACEUTICALS INC (22)
ROCKET PHARMACEUTICALS, INC. (10)
Rubius Therapeutics, Inc. (1)
Sage Therapeutics, Inc. (5)
Sana Biotechnology, Inc. (5)
SANGAMO THERAPEUTICS, INC (17)
Sarepta Therapeutics, Inc. (17)
Savara Inc (12)
Scholar Rock Holding Corp (1)
SEATTLE GENETICS INC (13)
SELECTA BIOSCIENCES INC (4)
SELLAS Life Sciences Group, Inc. (7)
Sensei Biotherapeutics, Inc. (2)
SERA PROGNOSTICS, INC. (6)
Seres Therapeutics, Inc. (6)
Sesen Bio, Inc. (10)
Shattuck Labs, Inc. (3)
Shuttle Pharmaceuticals Holdings, Inc. (1)
Sierra Oncology, Inc. (3)
Sigilon Therapeutics, Inc. (7)
Silverback Therapeutics, Inc. (3)
Social Capital Suvretta Holdings Corp. III (4)
SOLENO THERAPEUTICS INC (9)
Solid Biosciences Inc. (5)
SOLIGENIX, INC. (4)
SOPHIRIS BIO INC. (3)
Sorrento Therapeutics, Inc. (29)
Spectrum Pharmaceuticals, Inc. (6)
Spero Therapeutics, Inc. (2)
SPHERIX INC (8)
Spinning Eagle Acquisition Corp. (5)
Spring Bank Pharmaceuticals, Inc. (4)
SpringWorks Therapeutics, Inc. (3)
SPRUCE BIOSCIENCES, INC. (6)
SQZ Biotechnologies Co (2)
Stellar Biotechnologies, Inc. (1)
Stoke Therapeutics, Inc. (5)
Sun BioPharma, Inc. (2)
SUNESIS PHARMACEUTICALS INC (14)
Surface Oncology, Inc. (4)
SUTRO BIOPHARMA, INC. (5)
Syndax Pharmaceuticals Inc (21)
SYNLOGIC, INC. (5)
Synthetic Biologics, Inc. (16)
Syros Pharmaceuticals, Inc. (3)
T2 Biosystems, Inc. (7)
Talaris Therapeutics, Inc. (3)
Taysha Gene Therapies, Inc. (4)
TCR2 THERAPEUTICS INC. (3)
TENAX THERAPEUTICS, INC. (29)
Tenaya Therapeutics, Inc. (2)
TG THERAPEUTICS, INC. (10)
Therapeutics Acquisition Corp. (7)
Tocagen Inc (7)
Tonix Pharmaceuticals Holding Corp. (6)
Tracon Pharmaceuticals, Inc. (2)
Transcode Therapeutics, Inc. (4)
Translate Bio, Inc. (2)
TREVENA INC (8)
Trovagene, Inc. (4)
TScan Therapeutics, Inc. (3)
Turning Point Therapeutics, Inc. (3)
Twist Bioscience Corp (5)
TYME TECHNOLOGIES, INC. (6)
Tyra Biosciences, Inc. (2)
U.S. Stem Cell, Inc. (8)
Ultragenyx Pharmaceutical Inc. (17)
Unicycive Therapeutics, Inc. (3)
United Therapeutics Corp (3)
Unity Biotechnology, Inc. (5)
Unum Therapeutics Inc. (4)
UroGen Pharma Ltd. (4)
USA EQUITIES CORP. (1)
VACCINEX, INC. (12)
Vanda Pharmaceuticals Inc. (2)
Vaxart, Inc. (10)
Vaxcyte, Inc. (5)
Vaxxinity, Inc. (5)
VBI Vaccines Inc (2)
Vera Therapeutics, Inc. (6)
VERACYTE, INC. (7)
Verastem, Inc. (10)
Vericel Corp (11)
Vertex Pharmaceuticals Inc (38)
Verve Therapeutics, Inc. (3)
VICAL INC (8)
Vicapsys Life Sciences, Inc. (1)
Viela Bio, Inc. (1)
Vigil Neuroscience, Inc. (2)
Viking Therapeutics, Inc. (14)
Vir Biotechnology, Inc. (9)
Virios Therapeutics, LLC (2)
VistaGen Therapeutics, Inc. (3)
VITAL THERAPIES INC (1)
VITRO DIAGNOSTICS INC (15)
Vor Biopharma Inc. (2)
Voyager Therapeutics, Inc. (8)
vTv Therapeutics Inc. (11)
Werewolf Therapeutics, Inc. (2)
WINDTREE THERAPEUTICS INC (22)
XBiotech Inc. (1)
Xencor Inc (5)
Xenetic Biosciences, Inc. (5)
Xenon Pharmaceuticals Inc. (2)
Xilio Therapeutics, Inc. (3)
XOMA Corp (12)
YIELD10 BIOSCIENCE, INC. (12)
ZAFGEN, INC. (11)
Zai Lab Ltd (4)
Zentalis Pharmaceuticals, LLC (4)
ZIOPHARM ONCOLOGY INC (4)
Zymeworks Inc. (3)

Recent Contracts

Form of Notice of Grant of Restricted Stock Units Award (PIERIS PHARMACEUTICALS, INC., Filed With SEC on December 16, 2024)
Form of Stock Option Grant Notice and Stock Option Agreement (PIERIS PHARMACEUTICALS, INC., Filed With SEC on December 16, 2024)
Form of Common Stock Certificate (PIERIS PHARMACEUTICALS, INC., Filed With SEC on December 16, 2024)
Common Stock Purchase Agreement, dated December 9, 2024, by and between Exicure, Inc. and SangSangIn Investment & Securities Co., Ltd (EXICURE, INC., Filed With SEC on December 11, 2024)
Form of Restricted Stock Purchase Agreement (Aerovate Therapeutics, Inc., Filed With SEC on December 3, 2024)
Common Stock Certificate (HEMISPHERX BIOPHARMA INC, Filed With SEC on November 14, 2024)
Common Stock Purchase Agreement, dated November (EXICURE, INC., Filed With SEC on November 14, 2024)
Common Stock Purchase Agreement, dated November 6, 2024, by and between Exicure, Inc. and HiTron Systems, Inc (EXICURE, INC., Filed With SEC on November 14, 2024)
Common Stock Purchase Agreement, dated as of August 20, 2024, between Cell Source, Inc. and the investors identified therein (Cell Source, Inc., Filed With SEC on November 14, 2024)
Form of Restricted Stock Unit Agreement (Inducement Plan) (Grail, Inc., Filed With SEC on November 13, 2024)
Form of U.K. Inducement Restricted Stock Unit Grant Agreement (Replimune Group, Inc., Filed With SEC on November 12, 2024)
Form of U.K. Inducement Stock Option Grant Agreement (Replimune Group, Inc., Filed With SEC on November 12, 2024)
2018 Employee Stock Purchase Plan, as amended (Moderna, Inc., Filed With SEC on November 7, 2024)
Form of Common Stock Certificate (Aligos Therapeutics, Inc., Filed With SEC on November 6, 2024)
The Registrant's 2010 Employee Stock Purchase Plan (as amended and restated on July 31, 2024) (EXACT SCIENCES CORP, Filed With SEC on November 5, 2024)
Stock Issuance Agreement dated October 25, 2024, by and between the Company and Zentalis Pharmaceuticals, Inc (Immunome Inc., Filed With SEC on October 29, 2024)
Stock Sale and Purchase Agreement of NDPD Pharma, dated October 25, 2024 (BIOXYTRAN, INC, Filed With SEC on October 29, 2024)
Moleculin Biotech, Inc. 2024 Stock Plan (Moleculin Biotech, Inc., Filed With SEC on October 25, 2024)
Common Stock Investment Agreement between Alexion and Monopar dated as of October 23, 2024 (Monopar Therapeutics, Filed With SEC on October 24, 2024)
OnKure Therapeutics, Inc. 2024 Employee Stock Purchase Plan (Reneo Pharmaceuticals, Inc., Filed With SEC on October 8, 2024)
Form of Registration Rights Agreement dated as of October 2, 2024 relating to the resale of the shares of Common Stock underlying the Series C Preferred Stock and Warrants (Blue Water Vaccines Inc., Filed With SEC on October 3, 2024)
Form of Securities Purchase Agreement dated October 2, 2024 relating to the sale of the Series C Preferred Stock and Warrants (Blue Water Vaccines Inc., Filed With SEC on October 3, 2024)
Form of Class D Warrants to Purchase Common Stock (HEMISPHERX BIOPHARMA INC, Filed With SEC on October 1, 2024)
Form of Class C Warrants to Purchase Common Stock (HEMISPHERX BIOPHARMA INC, Filed With SEC on October 1, 2024)
Oruka Therapeutics, Inc. 2024 Employee Stock Purchase Plan (ARCA biopharma, Inc., Filed With SEC on September 5, 2024)
Stock Purchase (Graphite Bio, Inc., Filed With SEC on August 14, 2024)
Form of Common Stock Certificate (PIERIS PHARMACEUTICALS, INC., Filed With SEC on August 14, 2024)
Restricted Stock Agreement dated as of April 7, 2024 under the 2014 Global Share Option Plan between Brainstorm Cell Therapeutics Inc. and Uri Yablonka (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on August 14, 2024)
Restricted Stock Agreement dated as of April 21, 2024 under the 2014 Global Share Option Plan between Brainstorm Cell Therapeutics Inc. and Alla Patlis (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on August 14, 2024)
Restricted Stock Agreement dated as of June 3, 2024 under the 2014 Global Share Option Plan between Brainstorm Cell Therapeutics Inc. and Chaim Lebovits (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on August 14, 2024)
Stock Purchase Agreement, by and between MiNK Therapeutics, Inc. and the investor named therein, dated May 13, 2024 (MiNK Therapeutics, Inc., Filed With SEC on August 13, 2024)
Amended 2018 Employee Stock Purchase Plan (SUTRO BIOPHARMA, INC., Filed With SEC on August 13, 2024)
Form of Stock Option Grant Notice and Option Agreement and Form of Restricted Stock Unit Award Agreement and Form of Restricted Stock Unit Awar (CHIMERIX INC, Filed With SEC on August 13, 2024)
Description of the Companys Common Stock (Taysha Gene Therapies, Inc., Filed With SEC on August 12, 2024)
Form of Restricted Stock Unit (Emerald Bioscience, Inc., Filed With SEC on August 9, 2024)
Form of Stock Option Grant (Emerald Bioscience, Inc., Filed With SEC on August 9, 2024)
Common Stock Option and Purchase Agreement, dated May 22, 2024, by and between Royalty Pharma Investments 2019 ICAV and the Company (Cytokinetics, Incorporated, Filed With SEC on August 9, 2024)
Form of Non-Employee Director Restricted Stock Unit Agreement (BioAtla, Inc., Filed With SEC on August 8, 2024)
Dianthus Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended (Magenta Therapeutics, Inc., Filed With SEC on August 8, 2024)
Iovance Biotherapeutics, Inc. 2020 Employee Stock Purchase Plan, as amended (IOVANCE BIOTHERAPEUTICS, INC., Filed With SEC on August 8, 2024)